- Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer
-
Wang Y, Dong T, Xuan Q, Zhao H, Qin L, Zhang Q
- KMID: 2413930
- J Breast Cancer.
- 2018 Jun;21(2):124-133.
- doi: 10.4048/jbc.2018.21.2.124
PURPOSE: In this study, we aimed to evaluate lymphocyte-activation gene-3 (LAG-3) expression and its prognostic value in neoadjuvant-treated triple-negative breast cancer (TNBC). METHODS: LAG-3, programmed death-1 (PD-1), programmed death ligand-1 (PD-L1),... -
- CITED
-
- Close
- SHARE
-
- Close
